Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Domain-

PLXNA3 SON

8.27e-03333822.130.10.10
DomainWD40/YVTN_repeat-like_dom

PLXNA3 SON

8.36e-0333582IPR015943
Domain-

PLXNA3 IL1RL2

3.06e-02663822.60.40.10
DomainIg-like_fold

PLXNA3 IL1RL2

3.43e-0270682IPR013783
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PEG10 KIF1C

4.20e-041768237a73c1980db2a2b2da67742bf05f6a5cf936bbe
ToppCelldroplet-Tongue-nan-24m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SON KIF1C

4.20e-04176829739b0653c511ab017507a0c7ee4f6d7082e87db
ToppCellE16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PEG10 PLXNA3

4.24e-041778230f82b04e48940bfcaf2c22677efe6d57ae3f1a7
ToppCelldroplet-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SON KIF1C

4.29e-0417882a3176b2b335db22bb0fb71aafa5d7a287809396e
ToppCell10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

PEG10 IL1RL2

4.48e-0418282ed487f3a774812caa2903a646b60c86edcc1e65e
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PEG10 SON

5.09e-04194827a66bd7d4fc9c6db861cedd2487f241e406869d1
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PEG10 SON

5.09e-041948240c6e17e9e48d4fa6da3a0a1066c4c6565a1e096
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PEG10 SON

5.14e-041958232ec72103faccc9e37c0ecedff1998e7df6a19f6
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

PEG10 SON

5.30e-04198821847ce8c344c8a3e50f3cbbf758a38aba69f85b0
ToppCellkidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

EP400 SON

5.36e-0419982174f6013af6eafa577f84205a62927f2b367fda3
ToppCellBiopsy_IPF-Epithelial-Transitional_AT2|Biopsy_IPF / Sample group, Lineage and Cell type

PEG10 KIF1C

5.36e-041998283ff8b7e472d1212324c05cc719b746d19e5e23b
ToppCellTracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

IL1RL2 KIF1C

5.41e-042008261bae10c8b12196d9cee766897971b81cb897191
DrugBeraprost-d3

FOXL2 KIF1C

3.12e-047782CID000002352
Drugphytate

SON FOXL2

1.32e-0315982CID000000890
DrugCaptopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A

PEG10 SON

1.67e-03179824585_DN
Druggeldanamycin; Up 200; 1uM; HL60; HT_HG-U133A

PEG10 KIF1C

1.72e-03182822688_UP
Drug1-(2-trifluoromethoxyphenyl)-2-nitroethanone

EP400 SON

1.76e-0318482ctd:C576882
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

PEG10 SON

1.82e-03187824302_DN
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

PEG10 SON

1.84e-03188826735_DN
DrugMinocycline hydrochloride [13614-98-7]; Up 200; 8uM; HL60; HT_HG-U133A

PLXNA3 KIF1C

1.86e-03189822405_UP
DrugSolasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A

PEG10 KIF1C

1.90e-03191823830_UP
DrugCotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HG-U133A

PEG10 SON

1.92e-03192821929_DN
DrugHarmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; MCF7; HT_HG-U133A

PEG10 KIF1C

1.94e-03193826022_UP
DrugPiperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A

PEG10 KIF1C

1.94e-03193823845_UP
DrugMenadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A

PEG10 EP400

1.96e-03194824662_DN
DrugBenzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A

PLXNA3 KIF1C

1.96e-03194823169_DN
DrugNaloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HG-U133A

PEG10 SON

1.96e-03194821924_DN
DrugErythromycin [114-07-8]; Down 200; 5.4uM; PC3; HG-U133A

EP400 SON

1.98e-03195821928_DN
DrugSulfapyridine [144-83-2]; Up 200; 16uM; HL60; HT_HG-U133A

PEG10 PLXNA3

1.98e-03195822538_UP
DrugNorethindrone [68-22-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A

PEG10 PLXNA3

1.98e-03195825474_UP
DrugCefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; MCF7; HT_HG-U133A

PEG10 IL1RL2

1.98e-03195824148_UP
DrugKhellin [82-02-0]; Down 200; 15.4uM; PC3; HG-U133A

PEG10 SON

1.98e-03195821922_DN
DrugDipyridamole [58-32-2]; Down 200; 8uM; HL60; HG-U133A

EP400 SON

1.98e-03195822017_DN
DrugMetixene hydrochloride [1553-34-0]; Up 200; 11.6uM; HL60; HT_HG-U133A

PEG10 PLXNA3

2.00e-03196822451_UP
DrugAlverine citrate salt [5560-59-8]; Down 200; 8.4uM; PC3; HT_HG-U133A

PLXNA3 KIF1C

2.00e-03196822110_DN
Druggenistein; Up 200; 10uM; MCF7; HT_HG-U133A

PLXNA3 KIF1C

2.00e-03196825232_UP
DrugDiltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; PC3; HG-U133A

PEG10 SON

2.00e-03196821948_DN
DrugIpratropium bromide [22254-24-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A

PEG10 PLXNA3

2.00e-03196822762_UP
Drug3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A

PEG10 KIF1C

2.00e-03196826060_UP
DrugPentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A

PEG10 KIF1C

2.00e-03196823387_UP
DrugRibavirin [36791-04-5]; Up 200; 16.4uM; PC3; HT_HG-U133A

PEG10 PLXNA3

2.00e-03196827316_UP
DrugN-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A

PEG10 KIF1C

2.02e-03197823930_DN
DrugR(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A

SON KIF1C

2.02e-0319782164_DN
DrugTriamterene [396-01-0]; Up 200; 15.8uM; MCF7; HT_HG-U133A

PEG10 PLXNA3

2.02e-03197826010_UP
DrugEthambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A

PEG10 KIF1C

2.02e-03197824120_UP
DrugPilocarpine nitrate [148-72-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A

PLXNA3 KIF1C

2.02e-03197823300_DN
DrugFosfosal [6064-83-1]; Down 200; 18.4uM; MCF7; HT_HG-U133A

PLXNA3 SON

2.02e-03197824823_DN
DrugNaproxen [22204-53-1]; Down 200; 17.4uM; PC3; HT_HG-U133A

EP400 KIF1C

2.02e-03197821828_DN
DrugSelegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; HL60; HT_HG-U133A

PLXNA3 KIF1C

2.02e-03197822465_UP
DrugDiprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A

PEG10 KIF1C

2.02e-03197825482_UP
DrugOrlistat; Up 200; 10uM; MCF7; HT_HG-U133A

PEG10 KIF1C

2.02e-03197826383_UP
DrugPyrimethamine [58-14-0]; Down 200; 16uM; PC3; HG-U133A

PEG10 SON

2.02e-03197821894_DN
DrugProgesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A

PEG10 IL1RL2

2.02e-03197824992_UP
DrugDiltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; PC3; HG-U133A

PLXNA3 SON

2.02e-03197821948_UP
DrugHarmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A

PEG10 KIF1C

2.02e-03197825495_UP
DrugEthacrynic acid [58-54-8]; Down 200; 13.2uM; PC3; HT_HG-U133A

EP400 PLXNA3

2.04e-03198825742_DN
DrugFlucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A

PLXNA3 KIF1C

2.04e-03198826450_DN
DrugSulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HG-U133A

PEG10 SON

2.04e-03198821913_DN
DrugTiaprofenic acid [33005-95-7]; Up 200; 15.4uM; MCF7; HT_HG-U133A

PEG10 KIF1C

2.04e-03198824171_UP
DrugMethyldopa (L,-) [555-30-6]; Down 200; 19uM; HL60; HG-U133A

EP400 SON

2.04e-03198821619_DN
DrugClopamide [636-54-4]; Down 200; 11.6uM; PC3; HT_HG-U133A

EP400 KIF1C

2.04e-03198826301_DN
DrugMinaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; PC3; HG-U133A

PEG10 SON

2.04e-03198821888_DN
DrugDimenhydrinate [523-87-5]; Up 200; 8.6uM; HL60; HT_HG-U133A

PEG10 KIF1C

2.04e-03198822400_UP
DrugMethapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; HL60; HG-U133A

EP400 SON

2.06e-03199821588_DN
DrugPralidoxime chloride [51-15-0]; Up 200; 23.2uM; HL60; HT_HG-U133A

PEG10 KIF1C

2.06e-03199823066_UP
Drug2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A

PEG10 KIF1C

2.06e-03199825219_UP
DrugTocainide hydrochloride; Up 200; 17.4uM; HL60; HT_HG-U133A

PEG10 PLXNA3

2.06e-03199822931_UP
DrugNorgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A

PEG10 KIF1C

2.06e-03199823606_UP
DrugCaptopril [62571-86-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A

EP400 KIF1C

2.06e-03199821488_DN
Drugfludrocortisone acetate; Down 200; 1uM; MCF7; HG-U133A

EP400 KIF1C

2.08e-0320082282_DN
DrugPicotamide monohydrate [80530-63-8]; Up 200; 10.2uM; HL60; HG-U133A

EP400 SON

2.08e-03200821387_UP

Protein segments in the cluster

PeptideGeneStartEntry
RVPRPPPLYSHRMRI

EP400

1846

Q96L91
CYSKHYRSPPRPPMR

LCN9

161

Q8WX39
RCYPPPSMRVCAHRL

PLXNA3

76

P51805
RRRMKRPFRPPPAHF

FOXL2

146

P58012
RYHCRMYSPIPPSLP

PEG10

471

Q86TG7
PRYPPYTTPPRMRRQ

KIF1C

1076

O43896
TVRYHMPPRRCRPFP

IL1RL2

531

Q9HB29
DPYRMSPRPYRIAPR

SON

961

P18583